CLINICAL_TRIALS
trial_result
· 2019-05-07
Clinical Trial Update: LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients [Phase 4]
Summary
Phase 4 trial update on using Sofosbuvir/Ledipasvir for Hepatitis C in liver transplant recipients; results posted following completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2019-05-07